8-KMaterial AgreementsRegulation FDExhibits & Filings

Cencora, Inc. 8-K Report, Material Agreement (May 24, 2024)

Filed May 24, 2024For Securities:COR

Summary

Cencora, Inc. (COR) announced a significant share repurchase agreement with Walgreens Boots Alliance Holdings LLC, agreeing to buy back approximately 1.86 million shares of its common stock for around $400 million. This transaction, which closed on May 24, 2024, reduces Walgreens' stake to approximately 12% of Cencora's outstanding shares. Concurrently, Cencora raised its fiscal year 2024 adjusted diluted earnings per share guidance, signaling confidence in its ongoing performance and future prospects. This strategic move underscores Cencora's commitment to returning value to shareholders through share repurchases and reflects a positive outlook for the company's financial trajectory. Investors should monitor the impact of this buyback on future earnings per share and the ongoing relationship with Walgreens as a significant remaining shareholder.

Key Highlights

  • 1Cencora entered into a material definitive agreement to repurchase 1,859,390 shares of its common stock from Walgreens Boots Alliance Holdings LLC.
  • 2The total consideration for the share repurchase was approximately $400 million, with a price per share of $215.1244.
  • 3The repurchased shares were acquired on May 24, 2024, and will be held in treasury.
  • 4Following the repurchase, Walgreens Boots Alliance Holdings LLC now owns approximately 12% of Cencora's outstanding common stock.
  • 5The company also issued a press release announcing the repurchase and raising its fiscal year 2024 adjusted diluted earnings per share guidance.
  • 6The repurchase is consistent with Cencora's ongoing share repurchase programs.

Frequently Asked Questions

The primary purpose of this 8-K filing is to disclose a material definitive agreement entered into by Cencora for a significant share repurchase, and to provide updated financial guidance through a Regulation FD disclosure.

The share repurchase reduces the number of outstanding shares, which can increase earnings per share (EPS) assuming net income remains constant. The company's decision to repurchase shares also indicates confidence in its valuation and a commitment to returning capital to shareholders. The concurrent guidance increase suggests positive business performance.

Walgreens Boots Alliance Holdings LLC was the seller in this share repurchase. After the transaction, Walgreens remains a significant shareholder, owning approximately 12% of Cencora's outstanding common stock, but its ownership stake has been reduced.

Raising the adjusted diluted EPS guidance indicates that Cencora now expects to achieve higher earnings per share for the fiscal year 2024 than previously anticipated. This usually reflects positive business momentum, improved operational efficiency, or favorable market conditions.